chest strangled feeling of; dyspnoea; dizziness; perspiration excessive; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the medicines agency () -web. regulatory number: gr-greof-20217530 (greof). a 48 year-old female patient received bnt162b2 (comirnaty), intramuscular, administration date 29apr2021 (lot number: unknown) at the age of 48 years as dose number unknown, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: chest discomfort (medically significant) with onset 30apr2021, outcome "recovered" (30apr2021), described as "chest strangled feeling of"; dyspnoea (medically significant) with onset 30apr2021, outcome "recovered" (30apr2021), described as "dyspnoea"; dizziness (non-serious) with onset 30apr2021, outcome "recovered" (30apr2021), described as "dizziness"; hyperhidrosis (non-serious) with onset 30apr2021, outcome "recovered" (30apr2021), described as "perspiration excessive". the patient was vaccinated against covid-19 with the vaccine comirnaty on 29-apr-2021. the next day she presented with excessive perspiration, dizziness, feeling of strangled chest and dyspnoea. at the same day she went to a public hospital and she underwent a series of tests. nothing pathological was found. the patient underwent the following laboratory tests and procedures: laboratory test: (30apr2021) nothing pathological was found. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test date: 20210430; test name: series of tests; result unstructured data: test result:nothing pathological was found

na

na